investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Validation of Genomic Targets in Melanoma
Mohammed Kashani-Sabet
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Mohammed Kashani-Sabet
California Pacific Medical Center
San Francisco, United States
Related projects
Jeffrey S Weber
Rational Sequencing of PD-1 and CTLA-4 Antibodies in Metastatic Melanoma
Melanoma of skin
Baum S Jean
NMR studies of collagen model peptides and their interactions with collagen recep
Melanoma of skin
Israel David Goldman
Core Support for Cancer Center
Melanoma of skin
Charles J Dimitroff
Functional Analysis of Galectin-1 Ligands in Melanoma Progression
Melanoma of skin
Pathology
Meng Carla Wang
Lipid Signaling in Regulation of Longevity
Melanoma of skin
Gregory A Lizee
Using the MHC class I cytoplasmic tail to control tumor Ag presentation by DCs
Melanoma of skin
Gordon B. Mills
Biological annotation of TCGA data
Melanoma of skin
Amy R. Howell
Harnessing NKT Cell Activation by Glycolipids
Melanoma of skin
Jenny Hsu
A novel role for E2F4 as a transcriptional activator and a cell cycle driver
Melanoma of skin